Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 186 Total
BITF - Bitfarms Ltd. - Stock Price Chart
CompanyBitfarms Ltd.
IndustryCapital Markets
Market Cap625.51MEPS (ttm)-0.26
P/E-EPS this Y80.87%
Forward P/E-EPS next Y81.82%
PEG-EPS past 5Y-
P/S4.92EPS next 5Y-
P/B2.50EPS Q/Q83.06%
Dividend-Sales Q/Q4.06%
Insider Own6.46%Inst Own29.26%
Insider Trans0.00%Inst Trans-
Short Float5.35%EarningsNov 07/b
Analyst Recom1.00Target Price3.69
Avg Volume12.45M52W Range0.38 - 2.17
Bitfarms Ltd. (Canada) engages in the business of mining cryptocurrency. The firm is also involved in the ownership and operation of server farms comprised of computers designed for the purpose of validating transactions on the Bitcoin blockchain. The company was founded by Emiliano Joel Grodzki and Nicolas Bonta in 2017 and is headquartered in Toronto, Canada.
SRRK - Scholar Rock Holding Corp - Stock Price Chart
CompanyScholar Rock Holding Corp
Market Cap1.32BEPS (ttm)-2.25
P/E-EPS this Y16.00%
Forward P/E-EPS next Y3.41%
PEG-EPS past 5Y-17.91%
P/S-EPS next 5Y-
P/B6.12EPS Q/Q3.70%
Dividend-Sales Q/Q-
Insider Own23.67%Inst Own69.03%
Insider Trans61.71%Inst Trans-2.88%
Short Float18.70%EarningsNov 07/b
Analyst Recom1.00Target Price25.71
Avg Volume771.48K52W Range5.56 - 17.56
Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the development and discovery of innovative medicines. The firm offers proprietary platform which designed to discover and develop monoclonal antibodies that have a high degree of specificity to achieve selective modulation of growth factor signaling. Its product candidate includes SRK-015 and SRK-181. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Myles Edward HCOO & CFODec 07Option Exercise4.8624,914121,082193,698Dec 08 04:12 PM
Myles Edward HCOO & CFODec 07Sale17.5324,914436,820168,784Dec 08 04:12 PM
Myles Edward HCOO & CFONov 02Sale12.5135,007438,039168,784Nov 03 06:11 PM
Samsara BioCapital GP, LLC10% OwnerOct 16Buy6.852,189,78115,000,0006,788,609Oct 18 05:44 PM
AKKARAJU SRINIVASDirectorOct 16Buy6.852,189,78115,000,0006,788,609Oct 18 05:46 PM
AMRX - Amneal Pharmaceuticals Inc - Stock Price Chart
CompanyAmneal Pharmaceuticals Inc
IndustryDrug Manufacturers - Specialty & Generic
Market Cap780.20MEPS (ttm)0.06
P/E79.94EPS this Y-13.24%
Forward P/E8.69EPS next Y-1.36%
PEG-EPS past 5Y-
P/S0.33EPS next 5Y-1.50%
P/B2.36EPS Q/Q440.45%
Dividend0.30%Sales Q/Q13.65%
Insider Own64.58%Inst Own46.23%
Insider Trans-0.03%Inst Trans-0.47%
Short Float6.62%EarningsNov 07/b
Analyst Recom2.00Target Price6.12
Avg Volume1.27M52W Range1.24 - 4.79
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company that develops, manufactures, markets, and distributes a diverse portfolio of essential medicines, including complex generics and specialty-branded pharmaceuticals. The company operates through three reportable segments: Generics, Specialty, and AvKARE. The Generics segment includes a retail and institutional portfolio of approximately 260 product families covering an extensive range of dosage forms and delivery systems, including both immediate and extended release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, transdermal patches, and topicals. The Specialty segment is engaged in the development, promotion, sale, and distribution of proprietary branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson's disease, and endocrine disorders. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services primarily to governmental agencies, primarily focused on serving the Department of Defense and the Department of Veterans Affairs. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BOYER ANDREW SExecutive Vice PresidentAug 11Sale4.1329,302120,921244,739Aug 15 04:30 PM
TPG GP A, LLCFormer 10% OwnerDec 12Sale2.343,884,6009,095,40212,328,767Dec 14 05:01 PM
ALXO - Alx Oncology Holdings Inc - Stock Price Chart
CompanyAlx Oncology Holdings Inc
Market Cap610.79MEPS (ttm)-3.57
P/E-EPS this Y-13.57%
Forward P/E-EPS next Y4.11%
PEG-EPS past 5Y-58.82%
P/S-EPS next 5Y-
P/B2.99EPS Q/Q-42.96%
Dividend-Sales Q/Q-
Insider Own55.28%Inst Own43.71%
Insider Trans-0.05%Inst Trans1.08%
Short Float17.52%EarningsNov 13/a
Analyst Recom1.00Target Price16.92
Avg Volume1.28M52W Range3.94 - 12.33
TodayUpgrade Jefferies Hold → Buy $8 → $18
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pinto ShellyVP, Finance and CAOJul 06Sale6.527,34547,88955,713Jul 07 04:09 PM
Pons JaumePresident & CEOJun 30Sale7.343,20823,547536,538Jul 05 05:07 PM
Randolph SophiaChief Medical OfficerJun 30Sale7.341,60511,781281,477Jul 05 05:09 PM
GARCIA PETER SChief Financial OfficerJun 30Sale7.348876,51154,738Jul 05 05:00 PM
Pinto ShellyVP, Finance and CAOJun 30Sale7.344663,42063,058Jul 05 05:05 PM
CASI - CASI Pharmaceuticals Inc - Stock Price Chart
CompanyCASI Pharmaceuticals Inc
Market Cap93.77MEPS (ttm)-1.97
P/E-EPS this Y35.88%
Forward P/E-EPS next Y100.00%
PEG-EPS past 5Y-9.64%
P/S2.54EPS next 5Y-
P/B1.55EPS Q/Q47.74%
Dividend-Sales Q/Q26.48%
Insider Own54.97%Inst Own2.59%
Insider Trans0.00%Inst Trans-9.20%
Short Float2.52%EarningsNov 14/b
Analyst Recom1.00Target Price12.00
Avg Volume38.98K52W Range1.45 - 7.64
CASI Pharmaceuticals, Inc. engages in developing and commercializing therapeutics and pharmaceutical products. The company was founded in 1991 and is headquartered in Beijing, China.
APLT - Applied Therapeutics Inc - Stock Price Chart
CompanyApplied Therapeutics Inc
Market Cap240.19MEPS (ttm)-1.32
P/E-EPS this Y20.64%
Forward P/E-EPS next Y41.04%
PEG-EPS past 5Y-55.15%
P/S22.53EPS next 5Y-
P/B-EPS Q/Q-17.44%
Dividend-Sales Q/Q-
Insider Own32.26%Inst Own59.76%
Insider Trans-2.69%Inst Trans-9.56%
Short Float3.79%EarningsNov 09/b
Analyst Recom2.00Target Price14.00
Avg Volume1.03M52W Range0.70 - 3.11
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kanter Stacy J.DirectorDec 01Buy2.1830,00065,36763,000Dec 05 07:03 PM
Shendelman ShoshanaPresident and CEONov 30Sale1.973,9687,8172,596,387Dec 01 07:42 PM
Perfetti RiccardoChief Medical OfficerNov 30Sale1.971,5833,119692,341Dec 01 07:42 PM
Hansard AdamChief Commercial OfficerNov 30Sale1.979651,901381,790Dec 01 07:42 PM
ALEXANDRIA REAL ESTATE EQUITIE10% OwnerNov 03Sale2.31143,450331,3705,580,077Nov 06 04:56 PM
HOV - Hovnanian Enterprises, Inc. - Stock Price Chart
CompanyHovnanian Enterprises, Inc.
IndustryResidential Construction
Market Cap846.57MEPS (ttm)27.17
P/E5.12EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y104.89%
P/S0.31EPS next 5Y-
P/B1.90EPS Q/Q64.77%
Dividend-Sales Q/Q0.00%
Insider Own23.04%Inst Own46.63%
Insider Trans-5.84%Inst Trans-6.45%
Short Float4.75%EarningsDec 05/b
Analyst Recom3.00Target Price11.00
Avg Volume59.59K52W Range41.28 - 129.99
Hovnanian Enterprises, Inc. is a homebuilding company, which engages in the design, construction, and marketing of single-family attached town homes, attached townhomes and condominiums, urban infill, and lifestyle homes in planned residential developments. It operates through the following segments: Northeast, Southeast, and West. The Northeast segment consists of Delaware, Illinois, Maryland, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia. The Southeast segment focuses on Florida, Georgia, and South Carolina. The West segment includes Arizona, California, and Texas. The company was founded by Kevork S. Hovnanian in 1959 and is headquartered in Matawan, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KANGAS EDWARD ADirectorOct 09Sale86.215,500474,15528,743Oct 10 04:28 PM
HOVNANIAN ARA KChairman of Bd., Pres. & CEOJul 11Sale96.7250048,35951,075Jul 12 04:41 PM
HOVNANIAN ARA KChairman of Bd., Pres. & CEOJun 30Sale95.287,803743,49563,505Jul 05 06:10 PM
HOVNANIAN ARA KChairman of Bd., Pres. & CEOJun 29Sale95.062,197208,85171,308Jun 30 12:20 PM
HOVNANIAN ARA KChairman of Bd., Pres. & CEOJun 28Sale95.017,453708,07452,318Jun 28 06:54 PM
IRON - Disc Medicine Inc - Stock Price Chart
CompanyDisc Medicine Inc
Market Cap1.47BEPS (ttm)-3.74
P/E-EPS this Y92.78%
Forward P/E-EPS next Y-28.79%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B4.10EPS Q/Q23.32%
Dividend-Sales Q/Q-
Insider Own58.94%Inst Own44.61%
Insider Trans-12.90%Inst Trans4.25%
Short Float12.13%EarningsNov 09/b
Analyst Recom1.00Target Price67.11
Avg Volume189.57K52W Range11.80 - 58.98
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel treatments for hematologic disorders. Its programs include Bitopertin, DISC-0974, and DISC-3405. The company was founded in October 2017 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bryce JoanneChief Financial OfficerDec 05Option Exercise1.011,2811,2945,041Dec 07 04:15 PM
Bryce JoanneChief Financial OfficerDec 05Sale56.002,541142,2992,500Dec 07 04:15 PM
Khara RahulGeneral CounselNov 22Option Exercise14.6910,000146,90010,000Nov 27 04:15 PM
Khara RahulGeneral CounselNov 22Sale51.7310,000517,3330Nov 27 04:15 PM
Khara RahulGeneral CounselNov 14Option Exercise14.694,90071,9814,900Nov 15 05:00 PM
AAOI - Applied Optoelectronics Inc - Stock Price Chart
CompanyApplied Optoelectronics Inc
IndustryCommunication Equipment
Market Cap702.27MEPS (ttm)-2.12
P/E-EPS this Y51.82%
Forward P/E38.75EPS next Y204.79%
PEG-EPS past 5Y-
P/S3.21EPS next 5Y13.00%
P/B3.80EPS Q/Q51.33%
Dividend-Sales Q/Q10.33%
Insider Own8.52%Inst Own46.84%
Insider Trans-4.53%Inst Trans-3.31%
Short Float26.24%EarningsNov 09/a
Analyst Recom1.67Target Price16.75
Avg Volume2.32M52W Range1.60 - 18.66
Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lin Chih-Hsiang (Thompson)President and CEOSep 14Buy9.7915,000146,9011,252,471Sep 14 05:07 PM
Yeh Shu-Hua (Joshua)*** See RemarksSep 12Option Exercise9.9612,000119,520313,404Sep 14 04:01 PM
Lin Chih-Hsiang (Thompson)President and CEOSep 06Buy12.445,96474,1651,237,471Sep 06 04:01 PM
Lin Chih-Hsiang (Thompson)President and CEOAug 31Option Exercise9.9667,348670,7861,283,599Sep 05 07:09 PM
Murry Stefan J.Chief Financial OfficerAug 31Option Exercise9.9611,000109,560233,130Sep 05 07:09 PM
VIRC - Virco Manufacturing Corp. - Stock Price Chart
CompanyVirco Manufacturing Corp.
IndustryFurnishings, Fixtures & Appliances
Market Cap139.14MEPS (ttm)1.60
P/E5.32EPS this Y32.35%
Forward P/E4.95EPS next Y27.41%
PEG-EPS past 5Y-
P/S0.54EPS next 5Y-
P/B1.69EPS Q/Q58.66%
Dividend-Sales Q/Q29.62%
Insider Own25.40%Inst Own21.10%
Insider Trans-0.20%Inst Trans-0.81%
Short Float0.27%EarningsDec 08/b
Analyst Recom1.00Target Price12.00
Avg Volume134.29K52W Range3.54 - 8.24
Virco Manufacturing Corp. engages in the design, production and distribution of furniture. Its products include mobile tables, mobile storage equipment, desks, computer furniture, chairs, folding chairs and folding tables. The company was founded in February 1950 and is headquartered in Torrance, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Quinones Patricia LevineVice PresidentOct 17Sale7.751,47011,39667,803Oct 17 03:13 PM
Quinones Patricia LevineVice PresidentOct 16Sale7.873232,54269,273Oct 17 03:13 PM
Quinones Patricia LevineVice PresidentOct 09Sale7.877846,17069,596Oct 10 06:10 PM
Quinones Patricia LevineVice PresidentSep 29Sale7.942,00015,88070,380Oct 02 05:07 PM
Quinones Patricia LevineVice PresidentSep 28Sale7.332,78820,43572,380Sep 28 06:19 PM